Global Non-invasive Continuous Blood Glucose Monitors Market Growth 2024-2030

Publication ID:

LPI08250135

Publication Date:

August 14, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Manufacturers [2]

Machinery [3]

Industry & Manufacturing [4]

Description:

The global Non-invasive Continuous Blood Glucose Monitors market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淣on-invasive Continuous Blood Glucose Monitors Industry Forecast鈥� looks at past sales and reviews total world Non-invasive Continuous Blood Glucose Monitors sales in 2023, providing a comprehensive analysis by region and market sector of projected Non-invasive Continuous Blood Glucose Monitors sales for 2024 through 2030. With Non-invasive Continuous Blood Glucose Monitors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-invasive Continuous Blood Glucose Monitors industry.
This Insight Report provides a comprehensive analysis of the global Non-invasive Continuous Blood Glucose Monitors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-invasive Continuous Blood Glucose Monitors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Non-invasive Continuous Blood Glucose Monitors market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-invasive Continuous Blood Glucose Monitors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-invasive Continuous Blood Glucose Monitors.
United States market for Non-invasive Continuous Blood Glucose Monitors is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Non-invasive Continuous Blood Glucose Monitors is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Non-invasive Continuous Blood Glucose Monitors is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Non-invasive Continuous Blood Glucose Monitors players cover Afon Technology, Know Labs, Cnoga Medical, ESER Health Care Digital Technology, Nemaura Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-invasive Continuous Blood Glucose Monitors market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Continuous
Semi-Continuous
Segmentation by Application:
Hospital
Clinic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Afon Technology
Know Labs
Cnoga Medical
ESER Health Care Digital Technology
Nemaura Medical
DiaMonTech
Dexcom
Medtronic
FreeStyle Libre
Key Questions Addressed in this Report
What is the 10-year outlook for the global Non-invasive Continuous Blood Glucose Monitors market?
What factors are driving Non-invasive Continuous Blood Glucose Monitors market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-invasive Continuous Blood Glucose Monitors market opportunities vary by end market size?
How does Non-invasive Continuous Blood Glucose Monitors break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Non-invasive Continuous Blood Glucose Monitors Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Non-invasive Continuous Blood Glucose Monitors by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Non-invasive Continuous Blood Glucose Monitors by Country/Region, 2019, 2023 & 2030
2.2 Non-invasive Continuous Blood Glucose Monitors Segment by Type
2.2.1 Continuous
2.2.2 Semi-Continuous
2.3 Non-invasive Continuous Blood Glucose Monitors Sales by Type
2.3.1 Global Non-invasive Continuous Blood Glucose Monitors Sales Market Share by Type (2019-2024)
2.3.2 Global Non-invasive Continuous Blood Glucose Monitors Revenue and Market Share by Type (2019-2024)
2.3.3 Global Non-invasive Continuous Blood Glucose Monitors Sale Price by Type (2019-2024)
2.4 Non-invasive Continuous Blood Glucose Monitors Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Non-invasive Continuous Blood Glucose Monitors Sales by Application
2.5.1 Global Non-invasive Continuous Blood Glucose Monitors Sale Market Share by Application (2019-2024)
2.5.2 Global Non-invasive Continuous Blood Glucose Monitors Revenue and Market Share by Application (2019-2024)
2.5.3 Global Non-invasive Continuous Blood Glucose Monitors Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Non-invasive Continuous Blood Glucose Monitors Breakdown Data by Company
3.1.1 Global Non-invasive Continuous Blood Glucose Monitors Annual Sales by Company (2019-2024)
3.1.2 Global Non-invasive Continuous Blood Glucose Monitors Sales Market Share by Company (2019-2024)
3.2 Global Non-invasive Continuous Blood Glucose Monitors Annual Revenue by Company (2019-2024)
3.2.1 Global Non-invasive Continuous Blood Glucose Monitors Revenue by Company (2019-2024)
3.2.2 Global Non-invasive Continuous Blood Glucose Monitors Revenue Market Share by Company (2019-2024)
3.3 Global Non-invasive Continuous Blood Glucose Monitors Sale Price by Company
3.4 Key Manufacturers Non-invasive Continuous Blood Glucose Monitors Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-invasive Continuous Blood Glucose Monitors Product Location Distribution
3.4.2 Players Non-invasive Continuous Blood Glucose Monitors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Non-invasive Continuous Blood Glucose Monitors by Geographic Region
4.1 World Historic Non-invasive Continuous Blood Glucose Monitors Market Size by Geographic Region (2019-2024)
4.1.1 Global Non-invasive Continuous Blood Glucose Monitors Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Non-invasive Continuous Blood Glucose Monitors Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Non-invasive Continuous Blood Glucose Monitors Market Size by Country/Region (2019-2024)
4.2.1 Global Non-invasive Continuous Blood Glucose Monitors Annual Sales by Country/Region (2019-2024)
4.2.2 Global Non-invasive Continuous Blood Glucose Monitors Annual Revenue by Country/Region (2019-2024)
4.3 Americas Non-invasive Continuous Blood Glucose Monitors Sales Growth
4.4 APAC Non-invasive Continuous Blood Glucose Monitors Sales Growth
4.5 Europe Non-invasive Continuous Blood Glucose Monitors Sales Growth
4.6 Middle East & Africa Non-invasive Continuous Blood Glucose Monitors Sales Growth
5 Americas
5.1 Americas Non-invasive Continuous Blood Glucose Monitors Sales by Country
5.1.1 Americas Non-invasive Continuous Blood Glucose Monitors Sales by Country (2019-2024)
5.1.2 Americas Non-invasive Continuous Blood Glucose Monitors Revenue by Country (2019-2024)
5.2 Americas Non-invasive Continuous Blood Glucose Monitors Sales by Type (2019-2024)
5.3 Americas Non-invasive Continuous Blood Glucose Monitors Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-invasive Continuous Blood Glucose Monitors Sales by Region
6.1.1 APAC Non-invasive Continuous Blood Glucose Monitors Sales by Region (2019-2024)
6.1.2 APAC Non-invasive Continuous Blood Glucose Monitors Revenue by Region (2019-2024)
6.2 APAC Non-invasive Continuous Blood Glucose Monitors Sales by Type (2019-2024)
6.3 APAC Non-invasive Continuous Blood Glucose Monitors Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Non-invasive Continuous Blood Glucose Monitors by Country
7.1.1 Europe Non-invasive Continuous Blood Glucose Monitors Sales by Country (2019-2024)
7.1.2 Europe Non-invasive Continuous Blood Glucose Monitors Revenue by Country (2019-2024)
7.2 Europe Non-invasive Continuous Blood Glucose Monitors Sales by Type (2019-2024)
7.3 Europe Non-invasive Continuous Blood Glucose Monitors Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Non-invasive Continuous Blood Glucose Monitors by Country
8.1.1 Middle East & Africa Non-invasive Continuous Blood Glucose Monitors Sales by Country (2019-2024)
8.1.2 Middle East & Africa Non-invasive Continuous Blood Glucose Monitors Revenue by Country (2019-2024)
8.2 Middle East & Africa Non-invasive Continuous Blood Glucose Monitors Sales by Type (2019-2024)
8.3 Middle East & Africa Non-invasive Continuous Blood Glucose Monitors Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-invasive Continuous Blood Glucose Monitors
10.3 Manufacturing Process Analysis of Non-invasive Continuous Blood Glucose Monitors
10.4 Industry Chain Structure of Non-invasive Continuous Blood Glucose Monitors
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-invasive Continuous Blood Glucose Monitors Distributors
11.3 Non-invasive Continuous Blood Glucose Monitors Customer
12 World Forecast Review for Non-invasive Continuous Blood Glucose Monitors by Geographic Region
12.1 Global Non-invasive Continuous Blood Glucose Monitors Market Size Forecast by Region
12.1.1 Global Non-invasive Continuous Blood Glucose Monitors Forecast by Region (2025-2030)
12.1.2 Global Non-invasive Continuous Blood Glucose Monitors Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Non-invasive Continuous Blood Glucose Monitors Forecast by Type (2025-2030)
12.7 Global Non-invasive Continuous Blood Glucose Monitors Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Afon Technology
13.1.1 Afon Technology Company Information
13.1.2 Afon Technology Non-invasive Continuous Blood Glucose Monitors Product Portfolios and Specifications
13.1.3 Afon Technology Non-invasive Continuous Blood Glucose Monitors Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Afon Technology Main Business Overview
13.1.5 Afon Technology Latest Developments
13.2 Know Labs
13.2.1 Know Labs Company Information
13.2.2 Know Labs Non-invasive Continuous Blood Glucose Monitors Product Portfolios and Specifications
13.2.3 Know Labs Non-invasive Continuous Blood Glucose Monitors Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Know Labs Main Business Overview
13.2.5 Know Labs Latest Developments
13.3 Cnoga Medical
13.3.1 Cnoga Medical Company Information
13.3.2 Cnoga Medical Non-invasive Continuous Blood Glucose Monitors Product Portfolios and Specifications
13.3.3 Cnoga Medical Non-invasive Continuous Blood Glucose Monitors Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Cnoga Medical Main Business Overview
13.3.5 Cnoga Medical Latest Developments
13.4 ESER Health Care Digital Technology
13.4.1 ESER Health Care Digital Technology Company Information
13.4.2 ESER Health Care Digital Technology Non-invasive Continuous Blood Glucose Monitors Product Portfolios and Specifications
13.4.3 ESER Health Care Digital Technology Non-invasive Continuous Blood Glucose Monitors Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 ESER Health Care Digital Technology Main Business Overview
13.4.5 ESER Health Care Digital Technology Latest Developments
13.5 Nemaura Medical
13.5.1 Nemaura Medical Company Information
13.5.2 Nemaura Medical Non-invasive Continuous Blood Glucose Monitors Product Portfolios and Specifications
13.5.3 Nemaura Medical Non-invasive Continuous Blood Glucose Monitors Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Nemaura Medical Main Business Overview
13.5.5 Nemaura Medical Latest Developments
13.6 DiaMonTech
13.6.1 DiaMonTech Company Information
13.6.2 DiaMonTech Non-invasive Continuous Blood Glucose Monitors Product Portfolios and Specifications
13.6.3 DiaMonTech Non-invasive Continuous Blood Glucose Monitors Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 DiaMonTech Main Business Overview
13.6.5 DiaMonTech Latest Developments
13.7 Dexcom
13.7.1 Dexcom Company Information
13.7.2 Dexcom Non-invasive Continuous Blood Glucose Monitors Product Portfolios and Specifications
13.7.3 Dexcom Non-invasive Continuous Blood Glucose Monitors Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Dexcom Main Business Overview
13.7.5 Dexcom Latest Developments
13.8 Medtronic
13.8.1 Medtronic Company Information
13.8.2 Medtronic Non-invasive Continuous Blood Glucose Monitors Product Portfolios and Specifications
13.8.3 Medtronic Non-invasive Continuous Blood Glucose Monitors Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Medtronic Main Business Overview
13.8.5 Medtronic Latest Developments
13.9 FreeStyle Libre
13.9.1 FreeStyle Libre Company Information
13.9.2 FreeStyle Libre Non-invasive Continuous Blood Glucose Monitors Product Portfolios and Specifications
13.9.3 FreeStyle Libre Non-invasive Continuous Blood Glucose Monitors Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 FreeStyle Libre Main Business Overview
13.9.5 FreeStyle Libre Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂